605009.SH
豪悦护理
SSE · Consumer Defensive · Household & Personal Products · CN
CNY 24.41
+1.41%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.8B | 3.8B | 2.9B | 2.8B | 2.8B |
| Cost of Revenue | 2.6B | 2.6B | 2.1B | 2.0B | 2.2B |
| Gross Profit | 1.2B | 1.2B | 817.5M | 742.7M | 648.8M |
| Operating Expenses | |||||
| R&D Expense | 137.2M | 139.0M | 107.2M | 104.8M | 101.4M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 105.3M | 104.1M | 73.9M | 65.3M | 57.9M |
| Selling & Marketing Expense | 674.8M | 650.6M | 213.7M | 137.0M | 97.3M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 954.4M | 930.5M | 377.3M | 274.6M | 230.4M |
| Cost and Expenses | 3.6B | 3.5B | 2.5B | 2.3B | 2.4B |
| Operating Income (EBIT) | 261.2M | 265.3M | 461.2M | 507.9M | 456.2M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 265.2M | 269.0M | 460.8M | 507.9M | 456.4M |
| Income Tax Expense | 40.3M | 37.0M | 73.3M | 69.3M | 33.5M |
| Bottom Line | |||||
| Net Income | 224.9M | 232.0M | 387.5M | 438.6M | 422.9M |
| Earnings from Cont. Ops | 224.9M | 232.0M | 387.5M | 438.6M | 422.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 224.9M | 232.0M | 387.5M | 438.6M | 422.9M |
| Per Share | |||||
| Basic EPS | CN¥1.05 | CN¥1.08 | CN¥1.80 | CN¥2.84 | CN¥2.69 |
| Diluted EPS | CN¥1.05 | CN¥1.08 | CN¥1.80 | CN¥2.84 | CN¥2.70 |
| Revenue Per Share | CN¥17.84 | CN¥17.49 | CN¥13.61 | CN¥17.85 | CN¥17.83 |
| Shares | |||||
| Basic Shares Outstanding | 214.1M | 214.8M | 215.3M | 154.4M | 157.2M |
| Diluted Shares Outstanding | 214.1M | 214.8M | 215.3M | 154.4M | 157.2M |
| Profitability Metrics | |||||
| EBITDA | — | 437.6M | 586.4M | 630.8M | 541.4M |
| D&A | — | 172.3M | 125.2M | 122.9M | 85.3M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026